Influence of repeated maximal exercise testing on biomarkers and fatigue in sarcoidosis

Brain, Behavior, and Immunity

Volumn 33, Issue , 2013, Pages 57-64

  Braam, A W E ^a,d   de Haan, S N ^b   Vorselaars, A D M ^b   Rijkers, G T ^b,e   Grutters, J C ^b,c   van den Elshout, F J J ^a   Korenromp, I H E ^b  

^a RIJNSTATE HOSPITAL   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Beatrix Hospital   (Netherlands)

^e Roosevelt Academy   (Netherlands)

Author keywords

Exercise testing; Fatigue; Immune parameters; Sarcoidosis; Stress hormones

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; CYTOKINE; CYTOKINE RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; STRESS HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LUNG FUNCTION TEST; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SARCOIDOSIS; SLEEP TIME;

EXERCISE TESTING; FATIGUE; IMMUNE PARAMETERS; SARCOIDOSIS; STRESS HORMONES;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; PULMONARY GAS EXCHANGE; RECOVERY OF FUNCTION; RECURRENCE; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS, PULMONARY; SELF REPORT; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84883751417     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.05.006     Document Type: Article

References (36)

1. ATS Single breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique. Am. J. Respir. Crit. Care Med. 1995, 152:2185-2198.
2. ATS/ACCP Statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2003, 167:211-277.
3. Baughman R.P., Lower E.E., du Bois R.M. Sarcoidosis. The Lancet 2003, 361:1111-1118.
4. Baydur A., Alavy B., Nawathe A., Liu S., Louie S., Sharma O.P. Fatigue and plasma cytokine concentrations at rest and during exercise in patients with sarcoidosis. Clin. Respir. J. 2011, 5(3):156-164.
5. Besedovsky H.O., Del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocrinol. Rev. 1996, 17:64-102.
6. Costable U. Skeletal muscle weakness, fatigue and sarcoidosis. Thorax 2005, 60:1-2.
7. Cox C.E., Donohue J.F., Brown C.D., Kataria Y.P., Judson M.A. Health-related quality of life of persons with sarcoidosis. Chest 2004, 125:997-1004.
8. De Kleijn W.P., De Vries J., Lower E.E., Elfferich M.D., Baughmana R.P., Drent M.F. Fatigue in sarcoidosis: a systematic review. Curr. Opin. Pulm. Med. 2009, 15(5):499-506.
9. De Vries J., Rothkrantz-Kos S., van Dieijen-Visser M.P., Drent M. The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2004, 21(2):127-136.
10. Drent M., Lower E.E., De Vries J. Sarcoidosis associated fatigue. Eur. Respir. J. 2012, 40(1):255-263.
11. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 2000, 52:595-638.
12. Eskandari F., Webster J.I., Sternberg E.M. Neural immune pathways and their connection to inflammatory diseases. Arthritis Res. Ther. 2003, 5:251-265.
13. Hill E.E., Zack E., Battaglini C., Viru M., Viru A., Hackney A.C. Exercise and circulating cortisol levels: the intensity threshold effect. J. Endocrinol. Invest. 2008, 31:587-591.
14. Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N. Engl. J. Med. 2007, 357:2153-2165.
15. Korenromp I.H., Heijnen C.J., Vogels O.J., van den Bosch J.M., Grutters J.C. Characterization of chronic fatigue in patients with sarcoidosis in clinical remission. Chest 2011, 140(2):441-447.
16. Korenromp I.H., Grutters J.C., van den Bosch J.M., Heijnen C.J. Post-inflammatory fatigue in sarcoidosis: personality profiles, psychological symptoms and stress hormones. J. Psychosom. Res. 2012, 72:97-102.
17. Kruit A., Grutters J.C., Gerritsen W.B.M., Kos S., Wodzig W.K.W.H., Van den Bosch J.M.M., Ruven H.J.T. ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respir. Med. 2007, 101:510-515.
18. Marcellis R.G.J., Lenssen A.F., Elfferich M.D.P., de Vries J., Kassim S., Foerster K., Drent M. Exericise capacity, muscle strength and fatigue in sarcoidosis. Eur. Respir. J. 2011, 38:628-634.
19. Mastorakos G., Paltoglou G., Greene M., Ilias I., Papamichalopoulos A., Dimopoulos S., Pouliou E., Fatouros I.G., Nanas S. Inappropriately normal plasma ACTH and cortisol concentrations in the face of increased circulating interleukin-6 concentration in exercise in patients with sarcoidosis. Stress 2013, 16(2):202-210.
20. Matthews J.I., Hooper R.G. Exercise testing in pulmonary sarcoidosis. Chest 1983, 83:75-81.
21. Medinger A.E., Khouri S., Rohatgi K. The value of exercise testing. Chest 2001, 120:93-101.
22. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. ATS/ERS Task Force. Eur. Respir. J. 2005, 26:319-338.
23. Nater U.M., Maloney E., Boneva R.S., Gurbaxani B.M., Lin J.M., Jones J.F., Reeves W.C., Heim C. Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls. J. Clin. Endocrinol. Metab. 2008, 93:703-709.
24. Pedersen B.K., Steenberg A., Keller P., Keller C., Fischer C., Hiscock N., van Hall G., Plomgaard P., Febbraio M.A. Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immuun regulatory effect. Eur. J. Physiol. 2003, 446:9-16.
25. Prior C., Knight P.A., Herold M., Ott G., Spiteri M.A. Pulmonary sarcoidosis; patterns of cytokine release in vitro. Eur. Respir. J. 1996, 9:47-53.
26. Rothkrantz-Kos S., Van Dieijnen-Visser M.P., Mulder P.G. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin. Chem. 2003, 49:1510-1517.
27. Silverman M.N., Heim C.M., Nater U.M., Marques A.H., Sternberg E.M. Neuroendocrine and immune contributors to fatigue. PM R 2010, 2:338-346.
28. Spruit M.A., Thomeer M.J., Gosselink R., Troosters T., Kasran A., Debrock A.J., Demedts M.G., Decramer M. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 2005, 60:32-38.
29. Statement on Sarcoidosis Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am. J. Respir. Crit. Care Med. 1999, 160:736-755.
30. Steinberg J.G., Ba A., Brégeon F., Delliaux S., Jammes Y. Cytokine and oxidative responses to maximal cycling exercise in sedentary subjects. Med. Sci. Sports Exerc. 2007, 39(6):964-968.
31. Straub R.H., Cutolo M., Buttgereit F., Pongratz G. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J. Intern. Med. 2010, 267(6):543-560.
32. Van Den Eede F., Moorkens G., Van Houdenhove B., Cosyns P., Claes S.J. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. Neuropsychobiology 2007, 55:112-120.
33. Van der Zee K.I., Sanderman R. SF-36, Manual Dutch Version 1993, Noordelijk Centrum voor Gezondheidsvraagstukken, Groningen.
34. Vercoulen J.H., Swanink C.M., Fennis J.F., Galama J.M., van der Meer J.W., Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J. Psychosom. Res. 1994, 38(5):383-392.
35. Vercoulen J.H.M.M., Alberts M., Bleijenberg G. Kort instrumenteel: De Checklist Individual Strength [in Dutch]. Gedragstherapie 1999, 32:131-136.
36. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 1992, 30(6):473-483.